Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Philpott

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Scientific Reports|January 3, 2024
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivoElizabeth J Brown, Leire Balaguer-Lluna, Adam P Cribbs, et al.
Nature Methods|February 5, 2024
Correcting PCR amplification errors in unique molecular identifiers to generate accurate numbers of sequencing moleculesJianfeng Sun, Martin Philpott, Danson Loi, et al.
The Journal of Biological Chemistry|January 6, 2018
Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cellsAdam Cribbs, Edward S Hookway, Graham Wells, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomainSarah Picaud, Christopher Wells, Ildiko Felletar, et al.
Journal of Medicinal Chemistry|February 27, 2015
Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2BLudovic Drouin, Sally McGrath, Lewis R Vidler, et al.
Journal of Medicinal Chemistry|December 10, 2013
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomainsOleg Fedorov, Hannah Lingard, Chris Wells, et al.
Cancer Research|August 29, 2020
Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell DeathLucia Cottone, Adam P Cribbs, Garima Khandelwal, et al.
Cancer Research|April 12, 2013
PFI-1, a highly selective protein interaction inhibitor, targeting BET BromodomainsSarah Picaud, David Da Costa, Angeliki Thanasopoulou, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolismAdam P Cribbs, Stefan Terlecki-Zaniewicz, Martin Philpott, et al.
Experimental & Molecular Medicine|June 29, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancerOzlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Scientific Reports|January 3, 2024
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivoElizabeth J Brown, Leire Balaguer-Lluna, Adam P Cribbs, et al.
Nature Methods|February 5, 2024
Correcting PCR amplification errors in unique molecular identifiers to generate accurate numbers of sequencing moleculesJianfeng Sun, Martin Philpott, Danson Loi, et al.
The Journal of Biological Chemistry|January 6, 2018
Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cellsAdam Cribbs, Edward S Hookway, Graham Wells, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomainSarah Picaud, Christopher Wells, Ildiko Felletar, et al.
Journal of Medicinal Chemistry|February 27, 2015
Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2BLudovic Drouin, Sally McGrath, Lewis R Vidler, et al.
Journal of Medicinal Chemistry|December 10, 2013
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomainsOleg Fedorov, Hannah Lingard, Chris Wells, et al.
Cancer Research|August 29, 2020
Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell DeathLucia Cottone, Adam P Cribbs, Garima Khandelwal, et al.
Cancer Research|April 12, 2013
PFI-1, a highly selective protein interaction inhibitor, targeting BET BromodomainsSarah Picaud, David Da Costa, Angeliki Thanasopoulou, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolismAdam P Cribbs, Stefan Terlecki-Zaniewicz, Martin Philpott, et al.
Experimental & Molecular Medicine|June 29, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancerOzlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz, et al.
Pageof 8